- Home
- FHTX vs ACTG Comparison
FHTX vs ACTG Comparison
Compare FHTX & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FHTX | ACTG |
|---|---|---|
| Founded | 2015 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.4M | 384.9M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FHTX | ACTG |
|---|---|---|
| Price | $4.26 | $4.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $11.50 | $6.00 |
| AVG Volume (30 Days) | 106.1K | ★ 208.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.32 | ★ 161.11 |
| EPS | N/A | ★ 0.22 |
| Revenue | ★ $30,909,000.00 | $12,004,000.00 |
| Revenue This Year | $8.89 | N/A |
| Revenue Next Year | $20.13 | N/A |
| P/E Ratio | ★ N/A | $23.11 |
| Revenue Growth | ★ 36.75 | N/A |
| 52 Week Low | $3.27 | $3.12 |
| 52 Week High | $6.95 | $5.27 |
Technical Indicators
Market Signals| Indicator | FHTX | ACTG |
|---|---|---|
| Relative Strength Index (RSI) | 32.46 | 39.31 |
| Support Level | $3.65 | $3.18 |
| Resistance Level | $5.82 | $5.18 |
| Average True Range (ATR) | 0.29 | 0.14 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 10.00 | 25.66 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.